Seres Therapeutics Inc

MCRB

$26.71

+460.93% (1 year change)

Avg closing price

Price range

Market Cap

$2.2 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

Revenue

$1.42 Million

Total revenue in the last quarter.

Net Income

-$30.3 Million

Net income is all revenues minus all expenses including taxes and interest in the last quarter.

Earnings per Share

-$1.20

Earnings per share is the amount of net income that is attributed to each single share outstanding.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Price-Earnings Ratio

-24.55x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

EBIT

$-30 Million

Earnings before interest expenses and taxes in the last quarter.

Employees

0

The number of full time employees.

Revenue & Earnings

Balance Sheet

Seres Therapeutics Inc

News

A top biotech investor lays out why an entirely new approach to treating cancer and infections could finally pay off in 2021

A top biotech investor lays out why an entirely new approach to treating cancer and infections could finally pay off in 2021

Summary List Placement 2021 could be the year of the microbiome. That's at least one top healthcare venture capitalist's prediction. Venrock partner Racquel Bracken anticipates more success will co...

Business Insider Business Insider, 2 days ago
Flagship Pioneering Unveils Pioneering Medicines

Flagship Pioneering Unveils Pioneering Medicines

CAMBRIDGE, Mass. , Jan. 12, 2021 /PRNewswire/ -- Flagship Pioneering, a life science platforms company, today unveiled Pioneering Medicines, a new division of Flagship Pioneering. Initiated in 2020...

Benzinga Benzinga, 3 days ago
Seres Therapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference

Seres Therapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics, Inc. (Nasdaq: MCRB) today announced that it will present a corporate overview at the 39th Annual J.P. Morgan Healthcare Conference on Thursday...

Business Wire Business Wire, 9 days ago